๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ede
Clinical trial register · Netherlands

Clinical Trials in Ede, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3203 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:48 UTC
3203
Studies in scope
all four open statuses
1832
Recruiting now
open to new participants
608
Lead sponsors
across recruiting studies
Top sites
Amsterdam 19 's-Hertogenbosch 13 Amersfoort 13 Dordrecht 12 Arnhem 11
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Ede

4 of 3203 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Recruiting
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL
NCT05791409CLL/SLL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Groningen
2024-04-10
Active, closed
CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.
NCT04639362CLL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
85
Almere Stad, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Enschede, Gouda
2020-12-29
Recruiting
REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
NCT04523428CLL/SLL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
60
's-Hertogenbosch, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Ede, Eindhoven
2020-12-23
Active, closed
The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
NCT03463057NHL, DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
109
's-Hertogenbosch, Amersfoort, Amsterdam, Apeldoorn, Breda, Delft, Dordrecht, Ede
2018-08-30
Rows per page Showing 1–4 of 4
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-netherlands/city/ede

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,203 studies in total at the last sync on 26 Sep 2026, 19:48 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 4 of those studies with a site in Ede that also match the filters currently applied.

How many clinical trials are recruiting in Ede?

2 of the 4 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:48 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ede), 4 studies
PhaseStudiesRecruitingShare
Phase 23175%
Phase 1/21125%

Most active sponsors

Lead sponsors with the most studies (Ede)
Lead sponsorStudiesRecruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland42
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.